Results 71 to 80 of about 15,432 (213)
Key Regulators of Parasite Biology Viewed Through a Post‐Translational Modification Repertoire
ABSTRACT Parasites are the leading causes of morbidity and mortality in both humans and animals, imposing substantial socioeconomic burdens worldwide. Controlling parasitic diseases has become one of the key issues in achieving “One Health”. Most parasites have sophisticated life cycles exhibiting progressive developmental stages, morphologies, and ...
Naiwen Zhang, Ning Jiang, Qijun Chen
wiley +1 more source
Controlling kala azar in Assam
By exploring the state responses to kala azar in Assam during the early twentieth century, this review examines how, following the discovery of the parasite, efforts to halt the disease took on new forms, as questions about its communicability remained ...
Anidrita Saikia
doaj +1 more source
Field evaluation of rK39 test and direct agglutination test for diagnosis of visceral leishmaniasis in a population with high prevalence of human immunodeficiency virus in Ethiopia [PDF]
Accuracy of an rK39 rapid diagnostic test (DiaMed-IT-Leish ) for visceral leishmaniasis (VL) was compared with splenic aspiration and the direct agglutination test (DAT) in a population with a high prevalence of infection with human immunodeficiency ...
Assefa, Gessesse +5 more
core +1 more source
Uniting mathematics and biology for control of visceral leishmaniasis [PDF]
The neglected tropical disease (NTD) visceral leishmaniasis (VL) has been targeted by the WHO for elimination as a public health problem on the Indian subcontinent by 2017 or earlier.
Adams, ER +5 more
core +3 more sources
ABSTRACT Cutaneous leishmaniasis (CL) remains a therapeutic challenge in endemic regions, with 600,000–1 million new cases annually facing limited treatment options. We present a case series evaluating an innovative topical combination therapy for acute‐phase CL in Shiraz, Iran.
Hoda Haghshenas +3 more
wiley +1 more source
Leishmaniasis: new approaches to disease control. [PDF]
The leishmaniases afflict the world's poorest populations. Among the two million new cases each year in the 88 countries where the disease is endemic (fig 1), it is estimated that 80% earn less than $2 a day.
Croft, Simon L +3 more
core +2 more sources
Antileishmanial Activities of Carvacrol Nanoencapsulate in Biopolymeric Nanoparticles
The study obtained biopolymeric nanoparticles containing carvacrol (NPCar) and evaluated their anti‐leishmanial activity. NPCar obtained presented physicochemical characteristics due to its ideal nanometric size and zeta potential, and low polydispersity index.
Joyce Cordeiro Borges +6 more
wiley +1 more source
Risk factors of visceral leishmaniasis in East Africa: a case-control study in Pokot territory of Kenya and Uganda [PDF]
BACKGROUND: In East Africa, visceral leishmaniasis (VL) is endemic in parts of Sudan, Ethiopia, Somalia, Kenya and Uganda. It is caused by Leishmania donovani and transmitted by the sandfly vector Phlebotomus martini.
A. Ocheng +33 more
core +3 more sources
Background & objectives: In India, kala-azar surveillance is weak and no public-private partnership exists for disease containment. Estimate of disease burden is not reliably available and still cases are going to private providers for the treatment. The
N A Siddiqui +9 more
doaj
Notes sur les phlébotomes de l'Aïr (Niger) [PDF]
238 phlébotomes appartenant à 7 espèces ont été récoltés dans 4 stations du massif de l'Aïr au Niger. #Phlebotomus bergeroti$ était l'espèce dominante sur appât animal (âne) et dans les récoltes domiciliaires.
Jarry, D. +4 more
core

